复发性吉兰-巴雷综合征:临床特征和结果
K C Sudeep1, Arun Bansal2, Manjinder Singh Randhawa1
1Division of Pediatric Emergency and Intensive Care Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
Indian journal of pediatrics
|July 28, 2023
概括
复发性吉兰-巴雷综合征 (GBS) 不常见,先前的呼吸道或胃肠道疾病是潜在的预测因素. 复发性GBS发作的临床过程和结果与非复发性病例相似.
科学领域:
- 神经学 神经学
- 儿科重症监护室的儿童重症监护室
- 免疫学 免疫学 免疫学
背景情况:
- 吉兰-巴雷综合征 (GBS) 是一种罕见的自身免疫性疾病,影响周围神经系统.
- 复发性GBS虽然不常见,但会带来独特的临床挑战.
- 了解复发模式对于患者管理和资源分配至关重要.
研究的目的:
- 为了比较复发性GBS与非复发性GBS的临床,神经学,治疗和结果特征.
- 在复发病例中分析多次GBS发作之间的差异和相似之处.
- 为了确定GBS复发的潜在预测因素.
主要方法:
- 从2010年到2022年3月,对从2010年到2022年3月入住儿科重症监护室 (PICU) 的儿科GBS病例进行了回顾性分析.
- 临床资料的查,神经传导研究,治疗和结果数据.
- 应用国家神经和沟通疾病和中风研究所 (NINCDS) 标准来定义复发性GBS.
主要成果:
- 在4.7%的病例中 (11在234例中) 发现了复发性GBS.
- 之前的呼吸道和胃肠道疾病与GBS复发有显著的相关性 (p<0.05).
- 在复发性GBS和非复发性GBS的第一个发作之间,以及在复发性病例中的第一个和第二个发作之间,在临床过程或结果中没有观察到显著的差异.
结论:
- 复发性GBS是一个报告不足但被认可的临床实体.
- 复发性GBS发作的临床过程和结果与最初的GBS发作相似.
- 需要进一步的研究来确定经常性GBS的特定特征,以优化PICU资源利用和治疗计划.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K


